AVTR
Avantor, Inc.
NYSE · Healthcare · Medical - Instruments & Supplies · US
$15.52
−2.14%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$15.87
From 52W high−2.14%
Volume14.80M
Market cap$10.50B
P/E (TTM)—
P/S (TTM)1.6x
Div yield—
Key dataSep 18, 2026
Open
$15.87
From 52W high
−2.14%
Volume
14.80M
Market cap
$10.50B
ValuationView details →
P/E (Fwd)
18.0x
EV/EBITDA
110.8x
P/E (TTM)
—
RSI (14)
67.6
MomentumView details →
1D Return
−2.14%
YTD Return
+36.65%
SummaryUpdated Jun 1, 2026
Avantor, Inc. (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the life sciences and advanced technology industries. Founded in 1904 and headquartered in Radnor, Pennsylvania, the company went public in May 2019. Avantor serves customers across biopharma, healthcare, education and government, advanced technologies, and applied materials industries worldwide. The company has evolved from its origins as a specialty chemicals provider into a comprehensive solutions partner for organizations conducting critical research, development, and production activities.
Similar companies
Latest newsMore news →
Avantor expanded its RIM single-use bioprocessing portfolio across the Asia-Pacific region, increasing access to locally made bioprocessing solutions.2d agoMy Green Lab announced that more than 15 laboratory product distributors, procurement platforms, and laboratory analytics platforms have joined its ACT Ecolabel Channel Partner network to integrate independently verified sustainability data into purchasing workflows.12d ago